• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta.大鼠主动脉中α1肾上腺素能受体拮抗剂活性分析
Br J Pharmacol. 1996 May;118(2):299-310. doi: 10.1111/j.1476-5381.1996.tb15403.x.
2
Analysis of the effects of alpha 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery.α1肾上腺素能受体拮抗剂对去甲肾上腺素介导的大鼠小肠系膜动脉收缩作用的分析。
Br J Pharmacol. 1996 Jul;118(5):1308-16. doi: 10.1111/j.1476-5381.1996.tb15538.x.
3
Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline.介导大鼠主动脉对去甲肾上腺素收缩反应的α1D肾上腺素能受体的特性研究
Br J Pharmacol. 1995 Jul;115(6):981-6. doi: 10.1111/j.1476-5381.1995.tb15907.x.
4
Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.介导大鼠胸主动脉、肠系膜动脉和肺动脉对去氧肾上腺素收缩反应的α1肾上腺素能受体亚型的特性研究
Br J Pharmacol. 1997 Nov;122(5):849-58. doi: 10.1038/sj.bjp.0701461.
5
Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat.大鼠离体尾动脉中介导去甲肾上腺素收缩反应的α1A-肾上腺素能受体的药理学特性
Br J Pharmacol. 1997 Mar;120(5):819-26. doi: 10.1038/sj.bjp.0700983.
6
Pharmacological and immunocytochemical characterization of subtypes of alpha-1 adrenoceptors in dog aorta.犬主动脉中α-1肾上腺素能受体亚型的药理学和免疫细胞化学特性
J Pharmacol Exp Ther. 1998 May;285(2):894-901.
7
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.α1肾上腺素能受体拮抗剂在前列腺α1肾上腺素能受体上的药理选择性概况评估:结合、功能及体内研究
Br J Pharmacol. 1996 Jun;118(4):871-8. doi: 10.1111/j.1476-5381.1996.tb15480.x.
8
Investigation of the actions of chloroethylclonidine in rat aorta.氯乙可乐定对大鼠主动脉作用的研究。
Br J Pharmacol. 1995 Aug;115(8):1399-406. doi: 10.1111/j.1476-5381.1995.tb16630.x.
9
Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.介导兔皮肤阻力动脉血管收缩的α1-肾上腺素能受体亚型的研究。
Br J Pharmacol. 1997 Nov;122(5):825-32. doi: 10.1038/sj.bjp.0701451.
10
Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.介导大鼠主动脉、输精管和脾脏收缩的α1-肾上腺素能受体亚型的研究。
Br J Pharmacol. 1993 May;109(1):80-7. doi: 10.1111/j.1476-5381.1993.tb13534.x.

引用本文的文献

1
Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors.大鼠大脑皮质中α1L-肾上腺素能受体的鉴定以及α1L-与α1A-肾上腺素能受体之间的可能关系。
Br J Pharmacol. 2008 Apr;153(7):1485-94. doi: 10.1038/sj.bjp.0707679. Epub 2008 Jan 28.
2
Pharmacological properties of a wide array of ergolines at functional alpha(1)-adrenoceptor subtypes.多种麦角灵在功能性α₁肾上腺素能受体亚型上的药理特性。
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jan;376(5):321-30. doi: 10.1007/s00210-007-0221-3. Epub 2007 Dec 8.
3
Functional characterization of alpha 1-adrenoceptor subtypes in vascular tissues using different experimental approaches: a comparative study.使用不同实验方法对血管组织中α1-肾上腺素能受体亚型进行功能特性分析:一项比较研究。
Br J Pharmacol. 2003 Jan;138(2):359-68. doi: 10.1038/sj.bjp.0705033.
4
Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following beta-funaltrexamine-induced mu-opioid receptor "knockdown" in vivo.在体内β-芬太尼酰基诺啡诱导μ-阿片受体“敲低”后,大鼠中阿芬太尼脑电图效应的药代动力学-药效学分析
Pharm Res. 2000 Jun;17(6):653-9. doi: 10.1023/a:1007513812018.
5
Microphysiometric analysis of human alpha1a-adrenoceptor expressed in Chinese hamster ovary cells.对中国仓鼠卵巢细胞中表达的人α1a-肾上腺素能受体的微生理分析。
Br J Pharmacol. 1999 Jun;127(4):962-8. doi: 10.1038/sj.bjp.0702609.
6
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.新型α1A-肾上腺素能受体选择性拮抗剂Ro 70-0004和RS-100329的体外α1-肾上腺素能受体药理学
Br J Pharmacol. 1999 May;127(1):252-8. doi: 10.1038/sj.bjp.0702541.
7
A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype.去甲坡那定及其衍生物对α1A -肾上腺素能受体亚型选择性的一种可能结构决定因素。
Br J Pharmacol. 1996 Dec;119(8):1563-8. doi: 10.1111/j.1476-5381.1996.tb16073.x.
8
Analysis of the action of idazoxan calls into question the reliability of the rat isolated small mesenteric artery assay as a predictor for alpha 1-adrenoceptor-mediated pressor activity.咪唑克生作用的分析对大鼠离体小肠系膜动脉试验作为α1肾上腺素能受体介导的升压活性预测指标的可靠性提出了质疑。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep;354(3):389-92. doi: 10.1007/BF00171074.

本文引用的文献

1
A modification of receptor theory.受体理论的一种修正。
Br J Pharmacol Chemother. 1956 Dec;11(4):379-93. doi: 10.1111/j.1476-5381.1956.tb00006.x.
2
Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by RNase protection assay and comparison with alpha 1B and alpha 1D.用核糖核酸酶保护分析法检测成年大鼠组织中α1C-肾上腺素能受体mRNA的分布并与α1B和α1D进行比较。
Biochem Biophys Res Commun. 1994 May 16;200(3):1177-84. doi: 10.1006/bbrc.1994.1575.
3
The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.介导人类前列腺平滑肌收缩的α1肾上腺素能受体具有克隆的人类α1c亚型的药理学特性。
Mol Pharmacol. 1994 Apr;45(4):703-8.
4
Alpha 1-adrenoceptor subtype in the rat prostate is preferentially the alpha 1A type.大鼠前列腺中的α1肾上腺素能受体亚型主要是α1A 型。
Jpn J Pharmacol. 1993 Jul;62(3):297-304. doi: 10.1254/jjp.62.297.
5
Cardiovascular effects of chloroethylclonidine, an irreversible alpha 1B-adrenoceptor antagonist, in the unanesthetized rat: a pharmacological analysis in vivo and in vitro.不可逆性α1B -肾上腺素能受体拮抗剂氯乙可乐定对未麻醉大鼠的心血管作用:体内和体外药理学分析
J Pharmacol Exp Ther. 1993 Aug;266(2):864-71.
6
Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.介导大鼠主动脉、输精管和脾脏收缩的α1-肾上腺素能受体亚型的研究。
Br J Pharmacol. 1993 May;109(1):80-7. doi: 10.1111/j.1476-5381.1993.tb13534.x.
7
Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: implications for alpha 1-adrenergic receptor subtype classification.α1-肾上腺素能受体亚型mRNA在大鼠组织和人SK-N-MC神经细胞中的表达:对α1-肾上腺素能受体亚型分类的意义
Mol Pharmacol. 1994 Aug;46(2):221-6.
8
Comparison of cloned and pharmacologically defined rat tissue alpha 1-adrenoceptor subtypes.克隆的大鼠组织α1 - 肾上腺素能受体亚型与药理学定义的受体亚型的比较。
Naunyn Schmiedebergs Arch Pharmacol. 1994 Aug;350(2):136-42. doi: 10.1007/BF00241087.
9
Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.牛α1C - 肾上腺素能受体大鼠同源物的克隆、表达及组织分布为其归为α1A亚型提供了证据。
Mol Pharmacol. 1994 Nov;46(5):823-31.
10
Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classification.大鼠组织中α1 -肾上腺素能受体亚型的表达:对α1 -肾上腺素能受体分类的意义
Eur J Pharmacol. 1994 Jul 15;268(2):141-9. doi: 10.1016/0922-4106(94)90183-x.

大鼠主动脉中α1肾上腺素能受体拮抗剂活性分析

Analysis of the activity of alpha 1-adrenoceptor antagonists in rat aorta.

作者信息

Van der Graaf P H, Shankley N P, Black J W

机构信息

Department of Analytical Pharmacology, Rayne Institute, King's College School of Medicine and Dentistry, London.

出版信息

Br J Pharmacol. 1996 May;118(2):299-310. doi: 10.1111/j.1476-5381.1996.tb15403.x.

DOI:10.1111/j.1476-5381.1996.tb15403.x
PMID:8735631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1909637/
Abstract
  1. In this study, the effect of seven alpha 1-adrenoceptor antagonists (tamsulosin, phentolamine, prazosin, WB-4101, 5-methylurapidil, spiperone and HV723) have been examined on the contractile response to noradrenaline (NA) and phenylephrine (PE) in rat isolated aorta. 2. NA and PE, when administered using a cumulative dosing schedule, both produced concentration-dependent contraction of aortic rings. It was possible to fit the individual concentration-effect (E/[A]) curve data to the Hill equation to provide estimates of the curve midpoint location (p[A]50 = 7.74 +/- 0.10 and 7.14 +/- 0.18), midpoint slope (nH = 0.82 +/- 0.03 and 0.99 +/- 0.10) and upper asymptote (alpha = 3.2 +/- 0.3 and 3.1 +/- 0.2 g) parameters for NA and PE, respectively. However, the Hill equation provided a better fit to the E/[A] curve data obtained with another contractile agent, 5-hydroxytryptamine (5-HT) (p[A50] = 6.09 +/- 0.08, nH = 1.49 +/- 0.09, alpha = 2.6 +/- 0.3 g), as judged by calculation of the mean sum of squares of the differences between the observed and predicted values. 3. All of the antagonists investigated produced concentration-dependent inhibition of the contractile responses of the aorta to NA and PE. Although no significant effects on the upper asymptotes of the E/[A] curves of any of the antagonists tested were detected, only tamsulosin and 5-methylurapidil did not have a significant effect on the slope (nH) of the NA and PE E/[A] curves. The other antagonists produced significant steepening of the curves obtained with NA and/or PE. 4. Notwithstanding the fact that one of the basic criteria for simple competitive antagonism at a single receptor class was not always satisfied, the individual log [A]50 values estimated in the absence and presence of antagonist within each experiment were fitted to the competitive model. The Schild plot slope parameters for the antagonism of NA and PE by phentolamine and HV723 were found to be significantly less than unity. The Schild plot slope parameters for the other antagonists were not significantly different from unity. 5. In the absence of evidence to suggest that the deviations from simple competitive antagonism were due to failure to satisfy basic experimental conditions for quantitative analysis, an attempt was made to see whether the data could be accounted for by an existing two-receptor model (Furchgott, 1981). The goodness-of-fit obtained with the two-receptor model was significantly better than that obtained with the one-receptor model. Furthermore, with the exception of the data obtained with phentolamine, the pKB estimates for the two receptors were independent of whether NA or PE was used as agonist. 6. To determine which alpha 1-adrenoceptor subtypes may be associated with those defined by the two receptor model, the mean pKB estimates obtained from the two-receptor model fit were compared with affinities measured by Laz et al. (1994) for rat cloned alpha 1-adrenoceptor subtypes expressed in COS-7 cells. The sum of squared differences of the data points from the line of identity was smallest for both pKB1 and pKB2 in the case of the alpha 1a/d-adrenoceptor (now referred to as alpha 1d-adrenoceptor; Hieble et al., 1995). Therefore, the complexity exposed in this study may be due to the expression of closely-related forms of the alpha 1d-adrenoceptor. However, relatively good matches were also found between pKB1 and alpha 1c and between pKB2 and alpha 1b. Therefore, on the basis of these data, it is not possible to rule out the involvement of all three alpha 1-adrenoceptors. The conflicting reports concerning the characteristics of the alpha 1-adrenoceptor population mediating contraction of the rat aorta may, at least in part, be due to the lack of highly selective ligands and to between-assay variation in the expression of multiple alpha 1-adrenoceptors.
摘要
  1. 在本研究中,检测了七种α1肾上腺素能受体拮抗剂(坦索罗辛、酚妥拉明、哌唑嗪、WB - 4101、5 - 甲基乌拉地尔、螺哌隆和HV723)对大鼠离体主动脉对去甲肾上腺素(NA)和苯肾上腺素(PE)收缩反应的影响。2. 当采用累积给药方案给予NA和PE时,两者均使主动脉环产生浓度依赖性收缩。可以将各个浓度 - 效应(E/[A])曲线数据拟合到希尔方程,以分别提供NA和PE曲线中点位置(p[A]50 = 7.74±0.10和7.14±0.18)、中点斜率(nH = 0.82±0.03和0.99±0.10)以及上渐近线(α = 3.2±0.3和3.1±0.2 g)参数的估计值。然而,通过计算观测值与预测值之间差异的均方和判断,希尔方程对另一种收缩剂5 - 羟色胺(5 - HT)(p[A50] = 6.09±0.08,nH = 1.49±0.09,α = 2.6±0.3 g)获得的E/[A]曲线数据拟合得更好。3. 所研究的所有拮抗剂均对主动脉对NA和PE的收缩反应产生浓度依赖性抑制。尽管未检测到任何测试拮抗剂对E/[A]曲线的上渐近线有显著影响,但只有坦索罗辛和5 - 甲基乌拉地尔对NA和PE的E/[A]曲线斜率(nH)没有显著影响。其他拮抗剂使NA和/或PE获得的曲线显著变陡。4. 尽管在单一受体类别上简单竞争性拮抗的基本标准之一并非总是满足,但将每个实验中在不存在和存在拮抗剂时估计的各个log [A]50值拟合到竞争模型。发现酚妥拉明和HV723对NA和PE拮抗作用的希尔德图斜率参数显著小于1。其他拮抗剂的希尔德图斜率参数与1无显著差异。5. 在没有证据表明偏离简单竞争性拮抗是由于未能满足定量分析的基本实验条件的情况下,尝试查看数据是否可以用现有的双受体模型(弗奇戈特,1981)来解释。双受体模型获得的拟合优度明显优于单受体模型。此外,除了用酚妥拉明获得的数据外,两种受体的pKB估计值与使用NA还是PE作为激动剂无关。6. 为了确定哪些α1肾上腺素能受体亚型可能与双受体模型定义的亚型相关,将双受体模型拟合获得的平均pKB估计值与拉兹等人(1994年)测量的在COS - 7细胞中表达的大鼠克隆α1肾上腺素能受体亚型的亲和力进行比较。对于α1a/d - 肾上腺素能受体(现称为α1d - 肾上腺素能受体;希布尔等人,1995年),pKB1和pKB2的数据点与恒等线的平方差之和最小。因此,本研究中揭示的复杂性可能是由于α1d - 肾上腺素能受体密切相关形式的表达。然而,在pKB1与α1c以及pKB2与α1b之间也发现了相对较好的匹配。因此,基于这些数据,不能排除所有三种α1肾上腺素能受体的参与。关于介导大鼠主动脉收缩的α1肾上腺素能受体群体特征的相互矛盾的报道,至少部分可能是由于缺乏高选择性配体以及多种α1肾上腺素能受体表达的测定间差异。